Reports

Browse current and previous editions of Switzer Report

Monday Edition, 12 August 2024
Maureen Jordan

HOT stock: REA

Maureen Jordan · August 12, 2024

In our HOT stock column today, Raymond Chan, Head of Asian Desk, explains why Morgans maintains its HOLD rating for REA, with a BUY rating below $197.

Investing Premium
James Dunn

Two well-positioned aged care stocks

James Dunn · August 12, 2024

A wind of change has blown through the aged care sector. With a report just released from the Aged Care Taskforce and proposed legislation in the wings, there is at least the feeling that a blueprint for the future of our highly competitive but highly fragmented aged care sector is taking shape, promising greater regulatory clarity for investors. Here are two well-positioned stocks that could benefit from any changes.

Investing Premium
Rudi Filapek-Vandyck

Buy, Hold & Sell, What the Brokers Say…

Rudi Filapek-Vandyck · August 12, 2024

In the early stages of the August reporting season, during the week ending Friday 9 August 2024, FNArena recorded six ratings upgrades and two downgrades for ASX-listed companies by brokers monitored daily.

Broker Recommendations Premium
Switzer on Saturday, 10 August 2024
Peter Switzer

More sell offs likely, but I like what I see

Peter Switzer · August 10, 2024

The greatest lesson and insight from this week’s brutal market sell off (and then the rebound that produced the best day since November 2022 for the S&P 500) was the prevailing market belief that there’s another leg up for stocks.

Switzer on Saturday Premium
Thursday Edition, 8 August 2024
Maureen Jordan

HOT stock: Newmont (NEM)

Maureen Jordan · August 8, 2024

In our “HOT” stock column, Michael Gable, managing director of Fairmont Equities, explains why shares in Newmont (NEM) are a good buy right now, and should continue to head higher over time.

Investing Premium
Paul Rickard

Questions of the Week (8 August 2024)

Paul Rickard · August 8, 2024

Why can’t retail investors buy hybrid securities (bank capital notes)? Has CSL finally broken through $300? Why aren’t distributions from Transurban franked? What is the broker target price for Pro Medicus?

Q&A Premium
Tuesday Edition, 6 August 2024
Monday Edition, 5 August 2024
Peter Switzer

Stocks are falling but should you be a seller or a buyer?

Peter Switzer · August 5, 2024

Just when the data drops in the US were telling us that inflation was falling, rates were about to be cut and the Fed had engineered a soft landing, along came a weaker-than-expected jobs report that has led to recession fears. So, should you be afraid?

Investing Premium
Maureen Jordan

HOT stock: Resmed (RMD)

Maureen Jordan · August 5, 2024

For our “HOT” stock today, Raymond Chan, Head of Asian Desk at Morgans explains why Morgans considers Resmed (RMD) to be an ADD to an investment portfolio.

Investing Premium
James Dunn

Two speculative miners

James Dunn · August 5, 2024

Here are two situations where the odds might be on the side of the speculators! But always remember the risk.

Investing Premium
1 72 73 74 75 76 129

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.